The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease

被引:0
|
作者
Liu, Weiyang [1 ]
Wang, Cheng [1 ]
Tang, Sijie [1 ]
Ren, Jiayi [1 ]
Peng, Lijun [1 ]
Zhu, Yongmei [1 ]
Weng, Xiangqin [1 ]
Ouyang, Wanyan [1 ]
Xu, Jie [1 ]
Liu, Yuanfang [1 ]
Zhang, Weiping [1 ]
Wang, Jin [1 ]
Mi, Jian-Qing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, State Key Lab Med Gen, Natl Res Ctr Translat Med,Shanghai Inst Hematol, Shanghai, Peoples R China
关键词
D O I
10.1182/blood-2023-188733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
    Zuna, Jan
    Hovorkova, Lenka
    Krotka, Justina
    Koehrmann, Amelie
    Bardini, Michela
    Winkowska, Lucie
    Fronkova, Eva
    Alten, Julia
    Koehler, Rolf
    Eckert, Cornelia
    Brizzolara, Lisa
    Trkova, Marie
    Stuchly, Jan
    Zimmermann, Martin
    De Lorenzo, Paola
    Valsecchi, Maria Grazia
    Conter, Valentino
    Stary, Jan
    Schrappe, Martin
    Biondi, Andrea
    Trka, Jan
    Zaliova, Marketa
    Cazzaniga, Giovanni
    Cario, Gunnar
    LEUKEMIA, 2022, 36 (12) : 2793 - 2801
  • [22] The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation
    Zhang, Hao
    Liang, Zuyu
    Hu, Yongxian
    Wang, Xiujian
    Wang, Binsheng
    Huang, He
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 3018 - 3019
  • [23] A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or With T315I Mutation
    Gore, Lia
    Loh, Mignon
    Pui, Ching-Hon
    Matloub, Yousif
    Hanley, Michael J.
    Du, Jichang
    Hennessy, Meliessa
    Granier, Muriel
    Biondi, Andrea
    Silverman, Lewis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S190 - S191
  • [24] T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes
    Ting, Shi
    Mixue, Xie
    Lixia, Zhu
    Xueying, Li
    Wanzhuo, Xie
    Xiujin, Ye
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 829 - 834
  • [25] Second cord blood transplantation and interferon- maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation
    Sumi, Masahiko
    Sato, Keijiro
    Kaiume, Hiroko
    Takeda, Wataru
    Kirihara, Takehiko
    Ueki, Toshimitsu
    Hiroshima, Yuki
    Kobayashi, Hikaru
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 2005 - 2007
  • [26] T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes
    Shi Ting
    Xie Mixue
    Zhu Lixia
    Li Xueying
    Xie Wanzhuo
    Ye Xiujin
    Annals of Hematology, 2020, 99 : 829 - 834
  • [27] MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation
    Giles, Francis J.
    Cortes, Jorge
    Jones, Dan
    Bergstrom, Donald
    Kantarjian, Hagop
    Freedman, Steven J.
    BLOOD, 2007, 109 (02) : 500 - 502
  • [28] Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient
    How, Gee Fung
    Mueller, Martin C.
    Lim, Lay Cheng
    LEUKEMIA RESEARCH, 2012, 36 (01) : E20 - E21
  • [29] Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor, in Patients with Chronic Myeloid Leukemia Carrying the T315I Mutation in a Phase 1 Trial
    Rea, Delphine
    Lang, Fabian
    Kim, Dong-Wook
    Cortes, Jorge E.
    Hughes, Timothy P.
    Minami, Hironobu
    Breccia, Massimo
    Deangelo, Daniel J.
    Hochhaus, Andreas
    Talpaz, Moshe
    Goh, Yeow Tee
    le Coutre, Philipp
    Deininger, Michael W.
    Etienne, Gabriel
    Sondhi, Manu
    Mishra, Kaushal
    Aimone, Paola
    Ng-Sikorski, Janet
    Mauro, Michael J.
    BLOOD, 2018, 132
  • [30] Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Ohyashiki, Kazuma
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : 765 - 772